Results 301 to 310 of about 7,313,278 (356)

Genomics insights of candidiasis: mechanisms of pathogenicity and drug resistance. [PDF]

Front Microbiol
Huang X, Dong Q, Zhou Q, Fang S, Xu Y, Long H, Chen J, Li X, Qin H, Mu D, Cai X.   +10 more
europepmc   +1 more source

Current trends and landscape of drug resistance in renal cell carcinoma: a bibliometric analysis. [PDF]

Discov Oncol
Zhang K, Chen S, Zhou Z, Yu S, Zhan Y, Zhang X.   +5 more
europepmc   +1 more source

Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications. [PDF]

Int J Mol Sci
Kariya Y, Nishita M.
europepmc   +1 more source

Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota. [PDF]

PeerJ
Gan Y, Yang H, Wang M, Li J.
europepmc   +1 more source

Oral squamous cell carcinoma: Insights into cellular heterogeneity, drug resistance, and evolutionary trajectories. [PDF]

Cell Biol Toxicol
Zhou Y, Wang L, Liu M, Jiang H, Wu Y.
europepmc   +1 more source

Prevalence of Drug Resistance Mutations and their Association with Time to Virological Failure in People Living with HIV in Uganda

Ankunda C, Emunyu J, Namasambi S, Sserunjogi C, Kyomuhangi B, Mumbere I, Nakaweesi J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cancer drug resistance: an evolving paradigm

Nature Reviews Cancer, 2013
Daniel B Longley, S Sacerdoti
exaly   +2 more sources

Mechanisms of drug resistance in HCC

Hepatology, 2023
HCC comprises ∼80% of primary liver cancer. HCC is the only major cancer for which death rates have not improved over the last 10 years. Most patients are diagnosed with advanced disease when surgical and locoregional treatments are not feasible or ...
Alexandra D. Ladd, S. Duarte, I. Sahin, A. Zarrinpar   +3 more
semanticscholar   +1 more source

Drug Resistance

Drug Discovery Today: Technologies, 2014
Drug resistance is a fundamental problem in the treatment of cancer since cancer that becomes resistant to the available drugs may leave the patient with no therapeutic alternatives. In this chapter, we consider the dynamics of drug resistance in blood cancer and the related issue of the dynamics of cancer stem cells. After describing the main types of
Gemma, Texidó, Jürgen, Moll
  +6 more sources